Skip to main content

Congenital Heart Defects clinical trials at UCSD

1 in progress, 0 open to eligible people

Showing trials for
  • Erythropoietin to Prevent Unnecessary Transfusions In Patients With Cyanotic CHD - A Prospective Control Trial

    Sorry, in progress, not accepting new patients

    Cyanotic congenital cardiac patients require higher hemoglobin concentrations (red blood cell levels) for optimal oxygen delivery to the body. Prophylactic erythropoietin (EPO) and iron can prevent and/or decrease the amount of blood transfusions needed in this population. We seek to investigate if EPO and iron make a clinically significant difference in the number of transfusions given to these patients and the morbidity associated with it.

    San Diego, California

Last updated: